151 related articles for article (PubMed ID: 4053487)
1. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
[TBL] [Abstract][Full Text] [Related]
2. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.
Huey J; Thomas JP; Hendricks DR; Wehmeyer AE; Johns LJ; MacCosbe PE
Am J Hypertens; 1988 Jul; 1(3 Pt 3):284S-289S. PubMed ID: 3415804
[TBL] [Abstract][Full Text] [Related]
4. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
[TBL] [Abstract][Full Text] [Related]
5. Oral labetalol in hypertensive urgencies.
Zell-Kanter M; Leikin JB
Am J Emerg Med; 1991 Mar; 9(2):136-8. PubMed ID: 1994940
[TBL] [Abstract][Full Text] [Related]
6. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
7. Treatment of severe hypertension with intravenous labetalol.
Papademetriou V; Notargiacomo AV; Khatri IM; Freis ED
Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
[TBL] [Abstract][Full Text] [Related]
8. Oral labetalol versus oral clonidine in the emergency treatment of severe hypertension.
Atkin SH; Jaker MA; Beaty P; Quadrel MA; Cuffie C; Soto-Greene ML
Am J Med Sci; 1992 Jan; 303(1):9-15. PubMed ID: 1728876
[TBL] [Abstract][Full Text] [Related]
9. A dose-ranging study of labetalol in moderate to moderately severe hypertension.
Darmansjah I; Setiawati A; Prabowo P; Sukandar E; Parsoedi I; Ardaya ; Bahry B; Jusman J; Anggraeni E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):226-31. PubMed ID: 7620693
[TBL] [Abstract][Full Text] [Related]
10. Labetalol in severe and resistant hypertension.
Williams LC; Murphy MJ; Parsons V
Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
[TBL] [Abstract][Full Text] [Related]
11. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
Joekes AM; Thompson FD
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
[TBL] [Abstract][Full Text] [Related]
12. Comparison of labetalol versus enalapril as monotherapy in elderly patients with hypertension: results of 24-hour ambulatory blood pressure monitoring.
Applegate WB; Borhani N; DeQuattro V; Kaihlanen PM; Oishi S; Due DL; Sirgo MA
Am J Med; 1991 Feb; 90(2):198-205. PubMed ID: 1996588
[TBL] [Abstract][Full Text] [Related]
13. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
[TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of labetalol in severe hypertension.
Omvik P; Lund-Johansen P
J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
[TBL] [Abstract][Full Text] [Related]
15. Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED.
McDonald AJ; Yealy DM; Jacobson S
Am J Emerg Med; 1993 Sep; 11(5):460-3. PubMed ID: 8363681
[TBL] [Abstract][Full Text] [Related]
16. Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
Goldberg ME; Seltzer JL; Azad SS; Smullens SN; Marr AT; Larijani GE
J Cardiothorac Anesth; 1989 Aug; 3(4):411-7. PubMed ID: 2577702
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
[TBL] [Abstract][Full Text] [Related]
18. Rapid reduction of blood pressure with acute oral labetalol.
Davies AB; Bala Subramanian V; Gould B; Raftery EB
Br J Clin Pharmacol; 1982 May; 13(5):705-10. PubMed ID: 7082539
[TBL] [Abstract][Full Text] [Related]
19. Comparison in young and elderly patients of pharmacodynamics and disposition of labetalol in systemic hypertension.
Abernethy DR; Schwartz JB; Plachetka JR; Todd EL; Egan JM
Am J Cardiol; 1987 Sep; 60(8):697-702. PubMed ID: 3661438
[TBL] [Abstract][Full Text] [Related]
20. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
Dux S; Grosskopf I; Boner G; Rosenfeld JB
J Clin Pharmacol; 1986; 26(5):346-50. PubMed ID: 3700690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
